Human Papillomavirus Analysis as a Prognostic Marker Following Conization of the Cervix Uteri
- 31 July 1997
- journal article
- clinical trial
- Published by Elsevier BV in Gynecologic Oncology
- Vol. 66 (1), 108-113
- https://doi.org/10.1006/gyno.1997.4753
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control studyBMJ, 1996
- Cell cycle-dependent disruption of E2F-p107 complexes by human papillomavirus type 16 E7Journal of General Virology, 1995
- Prevalence of Human Papillomavirus in Cervical Cancer: a Worldwide PerspectiveJNCI Journal of the National Cancer Institute, 1995
- Epidemiologic Evidence Showing That Human Papillomavirus Infection Causes Most Cervical Intraepithelial NeoplasiaJNCI Journal of the National Cancer Institute, 1993
- Human Papillomaviruses, Tumour Suppressor Genes and Cervical CancerInternational Journal of STD & AIDS, 1993
- Biosynthesis of Human Papillomavirus from a Continuous Cell Line Upon Epithelial DifferentiationScience, 1992
- Invasive carcinoma of the uterine cervix following diagnosis and treatment of in situ carcinoma. Record linkage study within a National Cancer RegistryRadiotherapy and Oncology, 1989
- Evaluation of Screening for Cervical Cancer in Sweden: Trends in Incidence and Mortality 1958–1980International Journal of Epidemiology, 1985
- Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uterine cervix.A long-term prospective studyCancer, 1963
- Spontaneous course of cervical precancerous conditionsAmerican Journal of Obstetrics and Gynecology, 1956